肺部結節管理策略研究進展_Chinese Journal of Respiratory and Critical Care Medicine

Authors：

黃靜 ¹ , 沈慶 ¹ , 陳元瀾 ¹ ,  邊莉 ²

1. ;
2. ;

Corresponding?author：

邊莉, Email: bianli1976@sina.com

Keywords：

DOI：

10.7507/1671-6205.201706020

Video：

Export PDF Favorites Scan Get Citation

Abstract Full text Figures/Tables Video References Cited by

Citation： 黃靜, 沈慶, 陳元瀾, 邊莉. 肺部結節管理策略研究進展. Chinese Journal of Respiratory and Critical Care Medicine, 2018, 17(1): 97-101. doi: 10.7507/1671-6205.201706020 Copy

1.	Global Burden of Disease Cancer C; Fitzmaurice C, Dicker D, et al. The Global Burden of Cancer 2013. JAMA Oncol, 2015, 1(4): 505-527.
2.	Chen L, Engel BE, Welsh EA, et al. A sensitive NanoString-based assay to score STK11 (LKB1) pathway disruption in lung adenocarcinoma. J Thorac Oncol, 2016, 11(6): 838-849.
3.	Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin, 2017, 67(1): 7-30.
4.	Dhillon SS, Loewen G, Jayaprakash V, et al. Lung cancer screening update. J Carcinog, 2013, 12: 2.
5.	Simmons J, Gould MK, Iaccarino J, et al. Systems-level resources for pulmonary nodule evaluation in the United States: a national survey. Am J Respir Crit Care Med, 2016, 193(9): 1063-1065.
6.	Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology, 2008, 246(3): 697-722.
7.	Ruparel M, Quaife SL, Navani N, et al. Pulmonary nodules and CT screening: the past, present and future. Thorax, 2016, 71(4): 367-375.
8.	楊釗, 葉兆祥. 肺癌篩查中的問題和研究進展. 國際醫學放射學雜志, 2015, 38(6): 544-547.
9.	Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology, 2005, 235(1): 259-265.
10.	National Lung Screening Trial Research T; Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med, 2011, 365(5): 395-409.
11.	MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology, 2005, 237(2): 395-400.
12.	Naidich DP, Bankier AA, MacMahon H, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology, 2013, 266(1): 304-317.
13.	MacMahon H, Naidich DP, Goo JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology, 2017, 284(1): 228-243.
14.	中華醫學會呼吸病學分會肺癌學組, 中國肺癌防治聯盟專家組. 肺部結節診治中國專家共識. 中華結核和呼吸雜志, 2015, 38(4): 249-254.
15.	Kozielski J, Kaczmarczyk G, Porebska I, et al. Lung cancer in patients under the age of 40 years. Contemp Oncol (Pozn), 2012, 16(5): 413-415.
16.	Pesch B, Kendzia B, Fau-Gustavsson P, et al. Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer, 2012, 131(5): 1210-1219.
17.	Wang YX, Gong JS, Suzuki K, et al. Evidence based imaging strategies for solitary pulmonary nodule. J Thorac Dis, 2014, 6(7): 872-887.
18.	Cote ML, Liu M, Bonassi S, et al. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer, 2012, 48(13): 1957-1968.
19.	Erasmus JJ, Connolly JE, McAdams HP, et al. Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions. Radiographics, 2000, 20(1): 43-58.
20.	Wang WL, Shen-Tu Y, Wang ZQ. Prognostic factors for survival of stage IB upper lobe non-small cell lung cancer patients: a retrospective study in Shanghai, China. Chin J Cancer Res, 2011, 23(4): 265-270.
21.	Gaerte SC, Meyer CA, Winer-Muram HT, et al. Fat-containing lesions of the chest. Radiographics, 2002, 22 (Spec No 1): S61-S78.
22.	Ahn MI, Fau GT, Chan IH, et al. Perifissural nodules seen at CT screening for lung cancer. Radiology, 2010, 254(3): 949-956.
23.	Xu DM, van der Zaag-Loonen HJ, Oudkerk M, et al. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up. Radiology, 2009, 250(1): 264-272.
24.	Takashima S, Sone S, Li F, et al. Small solitary pulmonary nodules (< or =1 cm) detected at population-based CT screening for lung cancer: reliable high-resolution CT features of benign lesions. Am J Roentgenol, 2003, 180(4): 955-964.
25.	Wahidi MM, Govert JA, Goudar RK, et al. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest, 2007, 132(3 Suppl): 94s-107s.
26.	Tripathi S, Zhen XQ. Differentiation of benign and malignant solitary pulmonary nodule: literature review. Adv Lung Cancer, 2015, 4(2): 17-24.
27.	Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Brit J Radiol, 2000, 73(876): 1252-1259.
28.	彭彥, 王燕, 李峻嶺, 等. 血清 NSE、ProGRP 和 LDH 在小細胞肺癌診斷治療中的作用. 中國肺癌雜志, 2016, 19(9): 590-594.
29.	Lv SP, Wang Y, Huang L, et al. Meta-analysis of serum gastrin-releasing peptide precursor as a biomarker for diagnosis of small cell lung cancer. Asian Pac J Cancer Prev, 2017, 18(2): 391-397.
30.	Sho S, Court CM, Winograd P, et al. Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications. BMC Cancer, 2017, 17(1): 457.
31.	Inamura K. Diagnostic and therapeutic potential of microRNAs in lung cancer. Cancers (Basel), 2017, 9(5): 49.
32.	Nadal E, Truini A, Nakata A, et al. A novel serum 4-microRNA signature for lung cancer detection. Sci Rep, 2015, 5: 12464.
33.	許文景, 黃冬云, 陳平, 等. microRNA-Let-7a 在肺癌患者中的表達及其抑癌機制的探討. 中國免疫學雜志, 2016, 32(2): 234-238.
34.	蔣幼凡, 龐久高 , 薛亞梅. 肺癌患者血清及支氣管沖洗液中 EGF 的含量. 重慶醫科大學學報, 2000, 25(3): 169-171.
35.	Blanco-Prieto S, De Chiara L, Rodriguez-Girondo M, et al. Highly sensitive marker panel for guidance in lung cancer papid diagnostic units. Sci Rep, 2017, 7: 41151.
36.	邱小明, 喬艷潔, 劉斌, 等. DNA 甲基化在肺癌早期診斷中的研究進展. 中國肺癌雜志, 2012, 15(4): 234-241.
37.	Lu Y, Li S, Zhu S, et al. Methylated DNA/RNA in body fluids as biomarkers for lung cancer. Biol Proced Online, 2017, 19: 2.
38.	Wang L, Wu C, Qiao L, et al. Clinical significance of folate receptor-positive circulating tumor cells detected by ligand-targeted polymerase chain reaction in lung cancer. J Cancer, 2017, 8(1): 104-110.
39.	van't Westeinde SC, Horeweg N, Vernhout RM, et al. The role of conventional bronchoscopy in the workup of suspicious CT scan screen-detected pulmonary nodules. Chest, 2012, 142(2): 377-384.
40.	Steinfort DP, Khor YH, Manser RL, et al. Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer: systematic review and meta-analysis. Eur Respir J, 2011, 37(4): 902-910.
41.	唐純麗, 羅為展, 鐘長鎬, 等. 徑向超聲聯合虛擬導航引導肺活檢對肺外周結節的診斷價值. 中華結核和呼吸雜志, 2016, 39(1): 38-40.
42.	陳愉 , 李時悅. 電磁導航支氣管鏡臨床應用新進展. 中華結核和呼吸雜志, 2013, 36(1): 6-8.
43.	Hariri LP, Mino-Kenudson M, Lanuti M, et al. Diagnosing lung carcinomas with optical coherence tomography. Ann Am Thorac Soc, 2015, 12(2): 193-201.
44.	Sardi AH, Islam S. Early lung cancer detection, mucosal, and alveolar imaging. Curr Opin Pulm Med, 2016, 22(3): 271-280.
45.	Rampinelli C, De Marco P, Origgi D, et al, Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis. BMJ, 2017, 356(1756-1833): j347.
46.	Zhang J, Ou JX, Bai CX. Tobacco smoking in China: prevalence, disease burden, challenges and future strategies. Respirology, 2011, 16(8): 1165-1172.
47.	楊焱, 南奕, 屠夢吳, 等. 《2015 中國成人煙草調查報告》概要. 中華健康管理學雜志, 2016. 10(2): 85-87.

1. Global Burden of Disease Cancer C; Fitzmaurice C, Dicker D, et al. The Global Burden of Cancer 2013. JAMA Oncol, 2015, 1(4): 505-527.
2. Chen L, Engel BE, Welsh EA, et al. A sensitive NanoString-based assay to score STK11 (LKB1) pathway disruption in lung adenocarcinoma. J Thorac Oncol, 2016, 11(6): 838-849.
3. Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin, 2017, 67(1): 7-30.
4. Dhillon SS, Loewen G, Jayaprakash V, et al. Lung cancer screening update. J Carcinog, 2013, 12: 2.
5. Simmons J, Gould MK, Iaccarino J, et al. Systems-level resources for pulmonary nodule evaluation in the United States: a national survey. Am J Respir Crit Care Med, 2016, 193(9): 1063-1065.
6. Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society: glossary of terms for thoracic imaging. Radiology, 2008, 246(3): 697-722.
7. Ruparel M, Quaife SL, Navani N, et al. Pulmonary nodules and CT screening: the past, present and future. Thorax, 2016, 71(4): 367-375.
8. 楊釗, 葉兆祥. 肺癌篩查中的問題和研究進展. 國際醫學放射學雜志, 2015, 38(6): 544-547.
9. Swensen SJ, Jett JR, Hartman TE, et al. CT screening for lung cancer: five-year prospective experience. Radiology, 2005, 235(1): 259-265.
10. National Lung Screening Trial Research T; Aberle DR, Adams AM, et al. Reduced lung-cancer mortality with low-dose computed tomographic screening. N Engl J Med, 2011, 365(5): 395-409.
11. MacMahon H, Austin JH, Gamsu G, et al. Guidelines for management of small pulmonary nodules detected on CT scans: a statement from the Fleischner Society. Radiology, 2005, 237(2): 395-400.
12. Naidich DP, Bankier AA, MacMahon H, et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology, 2013, 266(1): 304-317.
13. MacMahon H, Naidich DP, Goo JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: from the Fleischner Society 2017. Radiology, 2017, 284(1): 228-243.
14. 中華醫學會呼吸病學分會肺癌學組, 中國肺癌防治聯盟專家組. 肺部結節診治中國專家共識. 中華結核和呼吸雜志, 2015, 38(4): 249-254.
15. Kozielski J, Kaczmarczyk G, Porebska I, et al. Lung cancer in patients under the age of 40 years. Contemp Oncol (Pozn), 2012, 16(5): 413-415.
16. Pesch B, Kendzia B, Fau-Gustavsson P, et al. Cigarette smoking and lung cancer--relative risk estimates for the major histological types from a pooled analysis of case-control studies. Int J Cancer, 2012, 131(5): 1210-1219.
17. Wang YX, Gong JS, Suzuki K, et al. Evidence based imaging strategies for solitary pulmonary nodule. J Thorac Dis, 2014, 6(7): 872-887.
18. Cote ML, Liu M, Bonassi S, et al. Increased risk of lung cancer in individuals with a family history of the disease: a pooled analysis from the International Lung Cancer Consortium. Eur J Cancer, 2012, 48(13): 1957-1968.
19. Erasmus JJ, Connolly JE, McAdams HP, et al. Solitary pulmonary nodules: Part I. Morphologic evaluation for differentiation of benign and malignant lesions. Radiographics, 2000, 20(1): 43-58.
20. Wang WL, Shen-Tu Y, Wang ZQ. Prognostic factors for survival of stage IB upper lobe non-small cell lung cancer patients: a retrospective study in Shanghai, China. Chin J Cancer Res, 2011, 23(4): 265-270.
21. Gaerte SC, Meyer CA, Winer-Muram HT, et al. Fat-containing lesions of the chest. Radiographics, 2002, 22 (Spec No 1): S61-S78.
22. Ahn MI, Fau GT, Chan IH, et al. Perifissural nodules seen at CT screening for lung cancer. Radiology, 2010, 254(3): 949-956.
23. Xu DM, van der Zaag-Loonen HJ, Oudkerk M, et al. Smooth or attached solid indeterminate nodules detected at baseline CT screening in the NELSON study: cancer risk during 1 year of follow-up. Radiology, 2009, 250(1): 264-272.
24. Takashima S, Sone S, Li F, et al. Small solitary pulmonary nodules (< or =1 cm) detected at population-based CT screening for lung cancer: reliable high-resolution CT features of benign lesions. Am J Roentgenol, 2003, 180(4): 955-964.
25. Wahidi MM, Govert JA, Goudar RK, et al. Evidence for the treatment of patients with pulmonary nodules: when is it lung cancer?: ACCP evidence-based clinical practice guidelines (2nd edition). Chest, 2007, 132(3 Suppl): 94s-107s.
26. Tripathi S, Zhen XQ. Differentiation of benign and malignant solitary pulmonary nodule: literature review. Adv Lung Cancer, 2015, 4(2): 17-24.
27. Hasegawa M, Sone S, Takashima S, et al. Growth rate of small lung cancers detected on mass CT screening. Brit J Radiol, 2000, 73(876): 1252-1259.
28. 彭彥, 王燕, 李峻嶺, 等. 血清 NSE、ProGRP 和 LDH 在小細胞肺癌診斷治療中的作用. 中國肺癌雜志, 2016, 19(9): 590-594.
29. Lv SP, Wang Y, Huang L, et al. Meta-analysis of serum gastrin-releasing peptide precursor as a biomarker for diagnosis of small cell lung cancer. Asian Pac J Cancer Prev, 2017, 18(2): 391-397.
30. Sho S, Court CM, Winograd P, et al. Precision oncology using a limited number of cells: optimization of whole genome amplification products for sequencing applications. BMC Cancer, 2017, 17(1): 457.
31. Inamura K. Diagnostic and therapeutic potential of microRNAs in lung cancer. Cancers (Basel), 2017, 9(5): 49.
32. Nadal E, Truini A, Nakata A, et al. A novel serum 4-microRNA signature for lung cancer detection. Sci Rep, 2015, 5: 12464.
33. 許文景, 黃冬云, 陳平, 等. microRNA-Let-7a 在肺癌患者中的表達及其抑癌機制的探討. 中國免疫學雜志, 2016, 32(2): 234-238.
34. 蔣幼凡, 龐久高 , 薛亞梅. 肺癌患者血清及支氣管沖洗液中 EGF 的含量. 重慶醫科大學學報, 2000, 25(3): 169-171.
35. Blanco-Prieto S, De Chiara L, Rodriguez-Girondo M, et al. Highly sensitive marker panel for guidance in lung cancer papid diagnostic units. Sci Rep, 2017, 7: 41151.
36. 邱小明, 喬艷潔, 劉斌, 等. DNA 甲基化在肺癌早期診斷中的研究進展. 中國肺癌雜志, 2012, 15(4): 234-241.
37. Lu Y, Li S, Zhu S, et al. Methylated DNA/RNA in body fluids as biomarkers for lung cancer. Biol Proced Online, 2017, 19: 2.
38. Wang L, Wu C, Qiao L, et al. Clinical significance of folate receptor-positive circulating tumor cells detected by ligand-targeted polymerase chain reaction in lung cancer. J Cancer, 2017, 8(1): 104-110.
39. van't Westeinde SC, Horeweg N, Vernhout RM, et al. The role of conventional bronchoscopy in the workup of suspicious CT scan screen-detected pulmonary nodules. Chest, 2012, 142(2): 377-384.
40. Steinfort DP, Khor YH, Manser RL, et al. Radial probe endobronchial ultrasound for the diagnosis of peripheral lung cancer: systematic review and meta-analysis. Eur Respir J, 2011, 37(4): 902-910.
41. 唐純麗, 羅為展, 鐘長鎬, 等. 徑向超聲聯合虛擬導航引導肺活檢對肺外周結節的診斷價值. 中華結核和呼吸雜志, 2016, 39(1): 38-40.
42. 陳愉 , 李時悅. 電磁導航支氣管鏡臨床應用新進展. 中華結核和呼吸雜志, 2013, 36(1): 6-8.
43. Hariri LP, Mino-Kenudson M, Lanuti M, et al. Diagnosing lung carcinomas with optical coherence tomography. Ann Am Thorac Soc, 2015, 12(2): 193-201.
44. Sardi AH, Islam S. Early lung cancer detection, mucosal, and alveolar imaging. Curr Opin Pulm Med, 2016, 22(3): 271-280.
45. Rampinelli C, De Marco P, Origgi D, et al, Exposure to low dose computed tomography for lung cancer screening and risk of cancer: secondary analysis of trial data and risk-benefit analysis. BMJ, 2017, 356(1756-1833): j347.
46. Zhang J, Ou JX, Bai CX. Tobacco smoking in China: prevalence, disease burden, challenges and future strategies. Respirology, 2011, 16(8): 1165-1172.
47. 楊焱, 南奕, 屠夢吳, 等. 《2015 中國成人煙草調查報告》概要. 中華健康管理學雜志, 2016. 10(2): 85-87.

Previous Article
機械通氣相關性肺損傷發生機制研究進展

Chinese Journal of Respiratory and Critical Care Medicine

肺部結節管理策略研究進展

Abstract Full text Figures/Tables Video References Cited by

Previous Article

Format

Content